Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CYSB2400146	甘精胰岛素注射液	insulin glargine	Injection	Biological Products(3.3)	Supplementary Application	2024-06-06	Yichang HEC Changjiang Pharmaceutical Co Ltd	view
CYSB2400140	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-06-01	Gan & Lee Pharmaceuticals	view
CYSB2400141	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-06-01	Gan & Lee Pharmaceuticals	view
CYSB2400113	甘精胰岛素注射液	insulin glargine	Injection	Biological Products(3.3)	Supplementary Application	2024-05-14	Wanbang Biopharmaceuticals	view
JYSB2400080	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-04-08		view
JYSB2400079	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-04-08		view
CYSB2400040	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-02-09	Gan & Lee Pharmaceuticals	view
CYSB2400041	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-02-09	Gan & Lee Pharmaceuticals	view
CYSB2300212	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2023-11-22	Sanofi (Beijing) Pharmaceuticals Co Ltd	view
CYSB2300211	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2023-11-22	Sanofi (Beijing) Pharmaceuticals Co Ltd	view
CYSB2300190	甘精胰岛素注射液	insulin glargine	Injection	Biological Products(3.3)	Supplementary Application	2023-10-26	Wanbang Biopharmaceuticals	view
CYSB2300082	甘精胰岛素注射液	insulin glargine	Injection	Biological Products(3.4)	Supplementary Application	2023-04-13	Shandong New Time Pharmaceutical Co Ltd	view
CYSB2300078	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2023-04-05	Gan & Lee Pharmaceuticals	view
CYSB2300079	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2023-04-05	Gan & Lee Pharmaceuticals	view
JYSZ2300012	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	License Renew	2023-02-28		view
JYSZ2300013	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	License Renew	2023-02-28		view
JXSS2200042	甘精胰岛素注射液	insulin glargine	Injection	Biological Products(3.3)	Import Drug Application	2022-12-27		view
JXSS2200043	甘精胰岛素注射液	insulin glargine	Injection	Biological Products(3.3)	Import Drug Application	2022-12-27		view
CXSS2200079	甘精胰岛素注射液	insulin glargine	Injection	Biological Products(3.3)	New Drug Application	2022-09-17	Hefei Tianmai BIOTECHNOLOGY Development Co Ltd	view
CYSB2200161	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2022-06-29	Sanofi (Beijing) Pharmaceuticals Co Ltd	view